ARTICLE | Clinical News
Human growth hormone (hGH): Completed Phase III trial enrollment
April 2, 2001 7:00 AM UTC
Cangene Corp. (TSE:CNJ), Mississauga, Ontario Product: Human growth hormone (hGH) Business: Metabolic, Generics Therapeutic category: Hormone replacement Target: hGH receptors Description: Subsequent ...